First Time Loading...

Covivio SA
PAR:COV

Watchlist Manager
Covivio SA Logo
Covivio SA
PAR:COV
Watchlist
Price: 49.8 EUR -0.6% Market Closed
Updated: May 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

26.5B
-4%
Assets
Growth Rates:
1 Year
-8%
3 Years
-2%
5 Years
+13%
7 Years
+36%
10 Years
+88%
17.8B
-2%
Liabilities
Growth Rates:
1 Year
-7%
3 Years
-4%
5 Years
+5%
7 Years
+22%
10 Years
+73%
8.7B
-8%
Equity
Growth Rates:
1 Year
-10%
3 Years
+3%
5 Years
+32%
7 Years
+78%
10 Years
+128%

Balance Sheet Decomposition
Covivio SA

26.5B
Assets
17.8B
Liabilities
26.5B
Assets
17.8B
Liabilities
Current Assets 1.8B
Cash & Short-Term Investments 474.6m
Receivables 640.9m
Other Current Assets 682.1m
Non-Current Assets 24.7B
Long-Term Investments 22.2B
PP&E 1.6B
Intangibles 136.6m
Other Non-Current Assets 776.4m
Current Liabilities 2.1B
Accounts Payable 290.1m
Accrued Liabilities 76.7m
Other Current Liabilities 1.7B
Non-Current Liabilities 15.7B
Long-Term Debt 10B
Other Non-Current Liabilities 5.7B

Balance Sheet
Covivio SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
382
1 027
950
1 083
1 297
1 172
1 302
1 246
1 063
462
Cash
226
340
213
207
564
663
676
669
437
442
Cash Equivalents
156
687
736
876
733
509
626
577
626
19
Total Receivables
497
398
357
411
435
482
589
470
726
575
Accounts Receivables
283
264
267
271
279
313
377
265
372
345
Other Receivables
215
134
90
141
156
169
212
206
354
230
Inventory
80
73
43
35
43
96
233
249
212
264
Other Current Assets
1 220
879
1 169
396
550
581
355
366
924
413
Total Current Assets
2 179
2 376
2 519
1 925
2 325
2 332
2 479
2 331
2 925
1 713
PP&E Net
108
80
89
151
204
1 242
1 489
1 442
1 393
1 580
PP&E Gross
108
80
89
151
204
1 242
1 489
1 442
1 393
1 580
Accumulated Depreciation
32
25
28
31
39
405
416
485
523
584
Intangible Assets
146
137
30
24
25
59
23
25
15
17
Goodwill
8
8
8
2
2
113
143
135
117
120
Note Receivable
94
143
166
177
144
97
204
264
116
97
Long-Term Investments
14 544
14 765
15 952
17 187
18 997
20 445
21 268
23 005
23 519
23 383
Other Long-Term Assets
102
56
49
35
37
97
113
178
153
750
Other Assets
8
8
8
2
2
113
143
135
117
120
Total Assets
17 181
N/A
17 566
+2%
18 813
+7%
19 500
+4%
21 733
+11%
24 384
+12%
25 720
+5%
27 380
+6%
28 237
+3%
27 661
-2%
Liabilities
Accounts Payable
110
87
111
114
168
213
229
218
228
214
Accrued Liabilities
107
106
87
76
82
105
121
71
107
76
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
919
1 135
1 015
1 292
1 461
1 797
1 783
1 805
1 736
1 186
Other Current Liabilities
461
397
539
337
384
460
555
459
739
445
Total Current Liabilities
1 597
1 726
1 753
1 819
2 095
2 575
2 688
2 553
2 810
1 921
Long-Term Debt
7 520
7 709
8 408
8 384
8 596
9 380
9 327
10 741
10 353
10 033
Deferred Income Tax
295
261
357
410
551
844
984
1 077
1 222
1 320
Minority Interest
2 925
3 142
3 089
3 166
3 804
3 797
4 061
3 986
4 429
4 648
Other Liabilities
554
570
567
420
323
226
363
441
230
295
Total Liabilities
12 891
N/A
13 408
+4%
14 174
+6%
14 198
+0%
15 370
+8%
16 823
+9%
17 422
+4%
18 798
+8%
19 044
+1%
18 218
-4%
Equity
Common Stock
188
188
200
206
224
249
262
284
284
284
Retained Earnings
1 826
1 725
2 025
2 647
3 312
3 805
4 181
4 190
4 819
5 144
Additional Paid In Capital
2 371
2 291
2 449
2 481
2 854
3 554
3 882
4 140
4 120
4 053
Treasury Stock
11
4
4
7
5
19
15
20
21
43
Other Equity
84
43
31
24
22
27
12
12
8
4
Total Equity
4 290
N/A
4 158
-3%
4 639
+12%
5 302
+14%
6 363
+20%
7 561
+19%
8 298
+10%
8 582
+3%
9 194
+7%
9 443
+3%
Total Liabilities & Equity
17 181
N/A
17 566
+2%
18 813
+7%
19 500
+4%
21 733
+11%
24 384
+12%
25 720
+5%
27 380
+6%
28 237
+3%
27 661
-2%
Shares Outstanding
Common Shares Outstanding
63
64
67
69
75
83
87
94
94
94

See Also

Summary
COV intrinsic value, competitors valuation, and company profile.
DCF Valuation
COV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
COV stock valuation using valuation multiples.
Wall Street Estimates
COV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
COV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.